About: Robert L Findling

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Robert L Findling Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher (ORCID 0000-0002-7654-5782)

Attributes	Values
rdf:type	Item
field of work	wds:Q90314248-6ede409b-4d33-7bf6-3776-c5fa9917c38d wds:Q90314248-986f8fe6-43fa-ccf3-9e4f-c01b723ba638 wds:Q90314248-a13ced4f-4173-cd71-d721-125e0bae06b6
field of work	child and adolescent psychiatry psychiatry psychopharmacology
description	ikertzailea (eu) 연구원 (ko) onderzoeker (nl) researcher (ORCID 0000-0002-7654-5782) (en)
rdfs:label	Robert L Findling (en) Robert L Findling (nl)
skos:prefLabel	Robert L Findling (en) Robert L Findling (nl)
name	Robert L Findling (en) Robert L Findling (nl)
Scopus author ID	wds:Q90314248-4b5d4b94-4c4b-b81f-b38c-4c6901c3437a
Scopus author ID	7006206342
given name	wds:Q90314248-0FF5A23E-EC16-4046-B3CE-348623D3ABAA
given name	Robert
image	wds:Q90314248-9b4b6c6a-43f0-3044-1063-c9fa33e60bd0
instance of	wds:Q90314248-F200CA28-6BBF-411D-BAD1-25270B0D7E50
image
instance of	Homo sapiens
ResearchGate profile ID	wds:Q90314248-a47bc701-4dfb-fd90-790d-5e6be41f5960
ResearchGate profile ID	Robert-Findling
skos:altLabel	Bob Findling (en) Robert Findling (en)
occupation	wds:Q90314248-692e117e-42b1-1ac3-553e-40242591fe0e wds:Q90314248-ED590B9D-3BD8-4A35-B4E1-9113B1334AC9
employer	wds:Q90314248-8124d78f-429d-883e-081f-d067298ce489
CiNii Research ID	wds:Q90314248-33CD344C-8705-4321-95F4-9E5D2026B260
sex or gender	wds:Q90314248-F17366D5-0F7F-4642-8A39-FBF54A923109
ISNI	wds:Q90314248-1AC513A1-8167-4DEE-AEA7-D4BF2C3DAAC8
VIAF ID	wds:Q90314248-B1D2C066-F1C3-42C0-9C9F-41734F453230
IdRef ID	wds:Q90314248-6553E405-2747-449E-978B-D6ADB0CD6FCA
NACSIS-CAT author ID	wds:Q90314248-BF9E4129-A409-40B5-8C6F-EDEF0FCAB171
date of birth	wds:Q90314248-355E83E8-33F1-4631-887E-72FDD8A7E4CD
family name	wds:Q90314248-2c88d12a-4044-d113-8034-68446ce2effa
National Library of Israel J9U ID	wds:Q90314248-01FDB78F-F1AC-4EAF-A11F-4D582F386F9F
CiNii Research ID	https://cir.nii.ac.jp/crid/1140563741794231552.rdf
VIAF ID	http://viaf.org/viaf/268592188
IdRef ID	http://www.idref.fr/090858360/id
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA14236683#entity
occupation	chairperson researcher
employer	Virginia Commonwealth University
CiNii Research ID	1140563741794231552
sex or gender	male
ISNI	0000000114906880
VIAF ID	268592188
IdRef ID	090858360
NACSIS-CAT author ID	DA14236683
date of birth	1961-01-01 00:00:00Z (xsd:dateTime)
family name	Finding
National Library of Israel J9U ID	987007454655605171
ORCID iD	wds:Q90314248-02BC1F06-3A0A-4284-A8E9-A132541A0D35
ORCID iD	https://orcid.org/0000-0002-7654-5782
ORCID iD	0000-0002-7654-5782
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q90314248
is author of	Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder Cyclothymic disorder: A critical review Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study The treatment of severe child aggression (TOSCA) study: Design challenges Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Examining the validity of cyclothymic disorder in a youth sample: replication and extension A prospective study of stimulant response in preschool children: insights from ROC analyses A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder Effects of the postpartum period on nortriptyline pharmacokinetics Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity Changes in emotions related to medication used to treat ADHD. Part I: literature review Early-onset bipolar spectrum disorders: diagnostic issues Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory Clinical decision-making using the General Behavior Inventory in juvenile bipolarity Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis Effects of adolescent manic symptoms on agreement between youth, parent, and teacher ratings of behavior problems. Early symptoms of mania and the role of parental risk. Evaluation and comparison of psychometric instruments for pediatric bipolar spectrum disorders in four age groups Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD Prolactin levels during long-term risperidone treatment in children and adolescents Neurocognition in early-onset schizophrenia and schizoaffective disorders Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia Medical and substance use comorbidity in bipolar disorder Discriminative validity of a parent version of the Young Mania Rating Scale Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software